ArticleFrontiers in oncology2022

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study.

Zhe Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.